Radiogenomics: a systems biology approach to understanding genetic risk factors for radiotherapy toxicity?
Adverse reactions in normal tissue after radiotherapy (RT) limit the dose that can be given to tumour cells. Since 80% of individual variation in clinical response is estimated to be caused by patient-related factors, identifying these factors might allow prediction of patients with increased risk o...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 November 2016
|
| In: |
Cancer letters
Year: 2016, Volume: 382, Issue: 1, Pages: 95-109 |
| ISSN: | 1872-7980 |
| DOI: | 10.1016/j.canlet.2016.02.035 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.canlet.2016.02.035 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0304383516301033 
|
| Author Notes: | Carsten Herskind, Christopher J. Talbot, Sarah L. Kerns, Marlon R. Veldwijk, Barry S. Rosenstein, Catharine M.L. West |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1666139378 | ||
| 003 | DE-627 | ||
| 005 | 20220816160233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190522s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canlet.2016.02.035 |2 doi | |
| 035 | |a (DE-627)1666139378 | ||
| 035 | |a (DE-599)KXP1666139378 | ||
| 035 | |a (OCoLC)1341225295 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Herskind, Carsten |d 1952- |e VerfasserIn |0 (DE-588)1028380488 |0 (DE-627)730637409 |0 (DE-576)375919325 |4 aut | |
| 245 | 1 | 0 | |a Radiogenomics |b a systems biology approach to understanding genetic risk factors for radiotherapy toxicity? |c Carsten Herskind, Christopher J. Talbot, Sarah L. Kerns, Marlon R. Veldwijk, Barry S. Rosenstein, Catharine M.L. West |
| 264 | 1 | |c 1 November 2016 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.05.2019 | ||
| 520 | |a Adverse reactions in normal tissue after radiotherapy (RT) limit the dose that can be given to tumour cells. Since 80% of individual variation in clinical response is estimated to be caused by patient-related factors, identifying these factors might allow prediction of patients with increased risk of developing severe reactions. While inactivation of cell renewal is considered a major cause of toxicity in early-reacting normal tissues, complex interactions involving multiple cell types, cytokines, and hypoxia seem important for late reactions. Here, we review ‘omics’ approaches such as screening of genetic polymorphisms or gene expression analysis, and assess the potential of epigenetic factors, posttranslational modification, signal transduction, and metabolism. Furthermore, functional assays have suggested possible associations with clinical risk of adverse reaction. Pathway analysis incorporating different ‘omics’ approaches may be more efficient in identifying critical pathways than pathway analysis based on single ‘omics’ data sets. Integrating these pathways with functional assays may be powerful in identifying multiple subgroups of RT patients characterised by different mechanisms. Thus ‘omics’ and functional approaches may synergise if they are integrated into radiogenomics ‘systems biology’ to facilitate the goal of individualised radiotherapy. | ||
| 650 | 4 | |a Gene expression microarrays | |
| 650 | 4 | |a Genome-wide association studies | |
| 650 | 4 | |a Normal-tissue reaction | |
| 650 | 4 | |a Predictive tests | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Single-nucleotide polymorphisms | |
| 700 | 1 | |a Veldwijk, Marlon Romano |d 1973- |e VerfasserIn |0 (DE-588)124783562 |0 (DE-627)366051938 |0 (DE-576)294500278 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer letters |d Amsterdam [u.a.] : Elsevier Science, 1975 |g 382(2016), 1, Seite 95-109 |h Online-Ressource |w (DE-627)320434796 |w (DE-600)2004212-7 |w (DE-576)261677926 |x 1872-7980 |7 nnas |a Radiogenomics a systems biology approach to understanding genetic risk factors for radiotherapy toxicity? |
| 773 | 1 | 8 | |g volume:382 |g year:2016 |g number:1 |g pages:95-109 |g extent:15 |a Radiogenomics a systems biology approach to understanding genetic risk factors for radiotherapy toxicity? |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.canlet.2016.02.035 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0304383516301033 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190522 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 124783562 |a Veldwijk, Marlon Romano |m 124783562:Veldwijk, Marlon Romano |d 60000 |d 63000 |e 60000PV124783562 |e 63000PV124783562 |k 0/60000/ |k 1/60000/63000/ | ||
| 998 | |g 1028380488 |a Herskind, Carsten |m 1028380488:Herskind, Carsten |d 60000 |d 63000 |e 60000PH1028380488 |e 63000PH1028380488 |k 0/60000/ |k 1/60000/63000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1666139378 |e 3478934664 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 22.05.2019"],"title":[{"title_sort":"Radiogenomics","title":"Radiogenomics","subtitle":"a systems biology approach to understanding genetic risk factors for radiotherapy toxicity?"}],"id":{"doi":["10.1016/j.canlet.2016.02.035"],"eki":["1666139378"]},"recId":"1666139378","language":["eng"],"origin":[{"dateIssuedDisp":"1 November 2016","dateIssuedKey":"2016"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"note":["Gesehen am 22.01.2020"],"disp":"Radiogenomics a systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Cancer letters","title":[{"title":"Cancer letters","title_sort":"Cancer letters","subtitle":"an international journal providing a forum for original and pertinent contributions in cancer research"}],"id":{"issn":["1872-7980"],"eki":["320434796"],"zdb":["2004212-7"]},"part":{"text":"382(2016), 1, Seite 95-109","volume":"382","issue":"1","extent":"15","year":"2016","pages":"95-109"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1975","dateIssuedDisp":"1975-","publisher":"Elsevier Science"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1975 -"],"recId":"320434796"}],"name":{"displayForm":["Carsten Herskind, Christopher J. Talbot, Sarah L. Kerns, Marlon R. Veldwijk, Barry S. Rosenstein, Catharine M.L. West"]},"person":[{"role":"aut","display":"Herskind, Carsten","given":"Carsten","roleDisplay":"VerfasserIn","family":"Herskind"},{"roleDisplay":"VerfasserIn","family":"Veldwijk","display":"Veldwijk, Marlon Romano","role":"aut","given":"Marlon Romano"}],"physDesc":[{"extent":"15 S."}]} | ||
| SRT | |a HERSKINDCARADIOGENOM1201 | ||